UC News


Stocks in news: Cipla, Maruti Suzuki and Bank of India

The Economic Times

Market Pulse- Cipla Plans Open Access To HIV Drug Patent

Bloomberg TV India

Cipla On USFDA Radar Again, Surprise Inspection Underway At Indore


In Business: EBIDTA Margin Target Of 21% For The Year: Cipla

Bloomberg TV India

Cipla, Lupin Q3 Results Today: Key Things To Watch Out For


Earnings Edge- Sun Pharma Q2 Profits Rise, While Cipla Misses Est

Bloomberg TV India

Cipla share price hits 52-week low as USFDA issues 12 observations for Goa facility

Business Today

Today's picks: From BPCL to Cipla, hot stocks to watch on Tuesday

Business Standard

Stocks in the news: DHFL, Cipla, GSK Pharma, Sterlite Tech, Future Enterprises, CG Power, SRF

Money Control

Cipla Q4 profit jumps over 2-fold to Rs 357 cr, beats Street estimates

The Economic Times-

Cipla Stocks Go Trending; Stocks In Focus - Acquires Drug Zemdri In The US


Superfast Futures: Ajanta pharma, Sun pharma, Cipla among top gainers of the day


US FDA Begins Inspections At Cipla's Goa Facility | BAZAAR MORNING CALL | January 22, 2019


How Are The Asian Markets Doing? Cipla MD Umang Vohra Speaks On The US Market


Earnings Corner: Cipla Preview

Dhamaal Mania

Cipla in focus after USFDA inspection at Goa facility

Business Standard

Cipla sales may be hit hard: Drugmaker may lose this much revenue in resolving USFDA quality worries


Cipla Q1 Consolidated Net Profit Rs 451.2 cr Vs Our Poll of Rs 422.6 cr (YoY) | #1QWithCNBCTV18


Cipla in focus after launch of Daptomycin

Business Standard

Cipla में HIV की एक दवा को US FDA से मंज़ूरी मिली | Cipla Stock Rallies | CNBC Awaaz

CNBC Awaaz